Skip to main content
Livermore
Livermore
ZHEN

Vanguard Group Inc

SEC CIK
0000102909
Latest filing
Jan 29, 2026

TNXP holding history

Tonix Pharmaceuticals Holding Corp. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TNXP overviewAll 13F holders of TNXPFull Q4 2025 holdings

Shares (Q4 2025)
673,605
Value
$10.5M
% of portfolio
<0.1%
Quarters held
18
Since Q1 2021
Holdings of TNXP by Vanguard Group Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 2025673,605$10.5M<0.1%+116,648+20.9%AddedHolders
Q3 2025556,957$13.5M<0.1%+392,225+238.1%AddedHolders
Q2 2025164,732$5.93M<0.1%+73,236+80.0%AddedHolders
Q1 202591,496$1.64M<0.1%+91,496NewHolders
Q3 20240$00.0%−25,395−100.0%Sold outHolders
Q2 202425,395$17.7K<0.1%−505,464−95.2%ReducedHolders
Q1 2024530,859$98.7K<0.1%+125,414+30.9%AddedHolders
Q4 2023405,445$163.4K<0.1%+7,300+1.8%AddedHolders
Q3 2023398,145$217.0K<0.1%−609−0.2%ReducedHolders
Q2 2023398,754$630.0K<0.1%+10,310+2.7%AddedConverted for a 4-for-25 splitHolders
Q1 20232,427,778$1.44M<0.1%+1,452,782+149.0%AddedHolders
Q4 2022974,996$380.1K<0.1%+116,580+13.6%AddedHolders
Q3 2022858,416$459.0K<0.1%+126,236+17.2%AddedHolders
Q2 2022732,180$1.16M<0.1%−17,576,646−96.0%ReducedHolders
Q1 202218,308,826$4.21M<0.1%−1,318,154−6.7%ReducedHolders
Q4 202119,626,980$7.02M<0.1%+3,620,360+22.6%AddedHolders
Q3 202116,006,620$9.62M<0.1%+240,081+1.5%AddedHolders
Q2 202115,766,539$17.5M<0.1%+1,088,377+7.4%AddedHolders
Q1 202114,678,162$18.8M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.